Non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatment

被引：1
|
作者：
Katsiki, Niki [1 ]
Athyros, Vasilios G. [2 ]
机构：
[1] AHEPA Univ Hosp, Dept Internal Med 1, Ctr Diabet Endocrinol & Metab, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Hippocrat Hosp, Med Sch, Propedeut Dept Internal Med 2, Thessaloniki, Greece
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2019年 / 35卷 / 07期
关键词：
FATTY LIVER-DISEASE; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR OUTCOMES; STATINS; RISK; BILIRUBIN; LIRAGLUTIDE;
D O I：
10.1080/03007995.2019.1589152
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1305 / 1306
页数：2
相关论文
共 50 条
  • [1] Response: non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatment
    Oshakbayev, Kuat
    Bimbetov, Bakytzhan
    Manekenova, Kenzhegul
    Bedelbayeva, Gulnara
    Mustafin, Khalit
    Dukenbayeva, Bibazhar
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (07) : 1307 - 1308
  • [2] Non-alcoholic steatohepatitis in type 2 diabetes mellitus
    Gupte, P
    Amarapurkar, D
    Agal, S
    Baijal, R
    Kulshrestha, P
    Pramanik, S
    Patel, N
    Madan, A
    Amarapurkar, A
    Hafeezunnisa
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (08) : 854 - 858
  • [3] A pilot study of empagliflozin for the treatment of non-alcoholic steatohepatitis in patients with type 2 diabetes mellitus
    Lai, L. L.
    Vethakkan, S.
    Mustapha, N. R. N.
    Mahadeva, S.
    Chan, W. -K.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S110 - S111
  • [4] Burden of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus
    Lauren Parlett
    Qinli Ma
    Qian Shi
    Geoffrey Crawford
    Laura Herrera Scott
    Vincent Willey
    Abiy Agiro
    Diabetology & Metabolic Syndrome, 13
  • [5] Burden of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus
    Parlett, Lauren
    Ma, Qinli
    Shi, Qian
    Crawford, Geoffrey
    Herrera Scott, Laura
    Willey, Vincent
    Agiro, Abiy
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [6] Type 2 diabetes mellitus complicated with smoldering myeloma and non-alcoholic steatohepatitis
    Nakahara, T
    Utsugi, T
    Ohyama, Y
    Tomono, S
    Sato, K
    Takagi, H
    Murakami, H
    Hasegawa, A
    Kurabayashi, M
    INTERNAL MEDICINE, 2005, 44 (08) : 838 - 842
  • [7] A Current Approach to Non-Alcoholic Steatohepatitis in Type 2 Diabetes Mellitus Patients
    Stan, Sorina I.
    Biciusca, Teodora
    Biciusca, Viorel
    Cioboata, Ramona
    Clenciu, Diana
    Mitrea, Adina
    Ghenea, Alice Elena
    Danoiu, Suzana
    GASTROENTEROLOGY INSIGHTS, 2023, 14 (03) : 363 - 382
  • [8] Non-alcoholic steatohepatitis (NASH) in children and adolescents with type 2 diabetes mellitus
    Newfield, R
    Schwimmer, J
    DIABETES, 2003, 52 : A404 - A404
  • [9] Sitagliptin for the Treatment of Non-Alcoholic Steatohepatitis in Patients With Type 2 Diabetes
    Malhotra, Neel
    Joy, Tisha R.
    McKenzie, Charles
    Beaton, Melanie
    GASTROENTEROLOGY, 2016, 150 (04) : S1142 - S1142
  • [10] Treatment with SGLT2 inhibitor dapagliflozin for non-alcoholic steatohepatitis patients complicated with type 2 diabetes mellitus
    Tobita, Hiroshi
    Sato, Shuiti
    Miyake, Tatuya
    Yazaki, Tomotaka
    Isoda, Kazuki
    Mishiro, Tuyoshi
    Ishihara, Shunji
    Kinoshita, Yoshikazu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 388 - 388
12345